Horan Securities’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-21
Closed -$3.08K 698
2023
Q2
$3.08K Hold
21
﹤0.01% 530
2023
Q1
$2.73K Hold
21
﹤0.01% 532
2022
Q4
$2.68K Hold
21
﹤0.01% 526
2022
Q3
$2K Buy
+21
New +$2.31K ﹤0.01% 512
2021
Q2
$0 Hold
1
﹤0.01% 496
2021
Q1
$0 Hold
1
﹤0.01% 465
2020
Q4
$0 Sell
1
-98
-99% -$13.8K ﹤0.01% 449
2020
Q3
$13K Buy
99
+1
+1% +$131 0.01% 197
2020
Q2
$11K Buy
+98
New +$11.3K 0.01% 168
2017
Q4
Sell
-82
Closed -$10K 210
2017
Q3
$10K Hold
82
0.01% 105
2017
Q2
$10K Hold
82
0.01% 99
2017
Q1
$10K Buy
+82
New +$9.29K 0.01% 92

Other funds holding ZBH

Horan Securities's ZBH Position: Q3 2023 in Review

Horan Securities sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 21 shares — an estimated $3.08K sold.

Horan Securities first reported a position in ZBH in Q1 2017 and held it in 12 quarters. The position peaked at $13K in Q3 2020. 1,015 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

  • Horan Securities reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
  • Horan Securities sold 21 Zimmer Biomet shares in Q3 2023, an estimated $3.08K.
  • Horan Securities first reported a position in Zimmer Biomet in Q1 2017 and held it in 12 quarters.
  • Horan Securities's Zimmer Biomet position peaked at $13K in Q3 2020.
  • 1,015 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Horan Securities's 13F filing for Q3 2023, filed 1 Nov 2023.